Cargando…

Comparison of post-COVID-19 vaccination hypermetabolic lymphadenopathy on (18)F-fluorodeoxyglucose PET/CT between virus-vector vaccine and mRNA vaccine

PURPOSE: We compared hypermetabolic lymphadenopathy (HLN) on (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) after virus-vector and mRNA vaccines for coronavirus disease 2019 (COVID-19). METHODS: This retrospective study included 573 participants who underw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiang, Meng-Ting, Wang, Jann-Tay, Lin, Wan-Yu, Yen, Ruoh-Fang, Huang, Jei-Yie, Lu, Ching-Chu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647177/ https://www.ncbi.nlm.nih.gov/pubmed/37964395 http://dx.doi.org/10.1186/s40001-023-01456-1

Ejemplares similares

Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy
por: Thaweerat, Wajana
Publicado: (2022)

Hypermetabolic Ipsilateral Supraclavicular and Axillary Lymphadenopathy: Optimal Time Point for Performing an (18)F-FDG PET/CT after COVID-19 Vaccination
por: Antwi, Kwadwo, et al.
Publicado: (2022)

[(18)F]FES PET Resolves the Diagnostic Dilemma of COVID-19-Vaccine-Associated Hypermetabolic Lymphadenopathy in ER-Positive Breast Cancer
por: Nogami, Munenobu, et al.
Publicado: (2023)

Role of [18F] FDG PET-CT in detection of COVID-19 vaccine-associated hypermetabolic lymphadenopathy (VAHL) in lymphoma patients: with serologic testing correlation
por: El Sammak, Dena Abd El Aziz, et al.
Publicado: (2023)

Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [(18)F]FDG PET-CT and relevance to study interpretation
por: Cohen, Dan, et al.
Publicado: (2021)

The Day after Mass COVID-19 Vaccination: Higher Hypermetabolic Lymphadenopathy Detection on PET/CT and Impact on Oncologic Patients Management
por: Ferrari, Cristina, et al.
Publicado: (2021)

A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [(18)F]FDG PET-CT studies performed in oncologic patients
por: Cohen, Dan, et al.
Publicado: (2021)

Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on (18)F-FDG PET/CT
por: Smith, Mathew V., et al.
Publicado: (2021)

False-Positive Hypermetabolic Lesions on Post-Treatment PET-CT after Influenza Vaccination
por: Kim, Jeong-Eun, et al.
Publicado: (2011)

Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy
por: Cohen, Dan, et al.
Publicado: (2021)

Hypermetabolic lymphadenopathy following the administration of COVID-19 vaccine and immunotherapy in a lung cancer patient: a case report
por: Tripathy, Shreya, et al.
Publicado: (2022)

Hypermetabolic Hurthle Cell Adenoma on (18)F-FDG PET/CT
por: Hassan, Aamna, et al.
Publicado: (2018)

Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: a computational approach to [18F]-fluorodeoxyglucose PET/CT images
por: Bauckneht, Matteo, et al.
Publicado: (2020)

Hypermetabolic lymphadenopathy on positron emission tomography scan following COVID‐19 vaccination: A mimicker of disease progression in Hodgkin lymphoma
por: Suleman, Adam, et al.
Publicado: (2021)

COVID-19 vaccine related hypermetabolic lymph nodes on PET/CT: Implications of inflammatory findings in cancer imaging
por: CALABRIA, FERDINANDO, et al.
Publicado: (2023)

Absolute Lymphocyte Count After COVID-19 Vaccination Is Associated with Vaccine-Induced Hypermetabolic Lymph Nodes on (18)F-FDG PET/CT: A Focus in Breast Cancer Care
por: Seban, Romain-David, et al.
Publicado: (2022)

Evolution of Lymphadenopathy at PET/MRI after COVID-19 Vaccination
por: Hanneman, Kate, et al.
Publicado: (2021)

Axillary Lymphadenopathy After mRNA COVID-19 Vaccination
por: Ahn, Richard W., et al.
Publicado: (2021)

Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F]Choline PET/CT—not only an FDG finding
por: Nawwar, Ayah Adel, et al.
Publicado: (2021)

(18)F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine
por: Steinberg, Julie, et al.
Publicado: (2021)

COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan
por: Singh, Balraj, et al.
Publicado: (2021)

Coincidence of Sarcoidosis and a COVID-19 vaccine-associated hypermetabolic lymphadenopathy in a patient with a history of invasive breast cancer: A case report
por: Kawabata, Asuka, et al.
Publicado: (2022)

COVID-19 vaccine as a cause for unilateral lymphadenopathy detected by 18F-FDG PET/CT in a patient affected by melanoma
por: Avner, Mordechai, et al.
Publicado: (2021)

Prevalence and Significance of Hypermetabolic Lymph Nodes Detected by 2-[(18)F]FDG PET/CT after COVID-19 Vaccination: A Systematic Review and a Meta-Analysis
por: Treglia, Giorgio, et al.
Publicado: (2021)

Aortic (18)F-FDG PET/CT hypermetabolism in patients with long COVID: a retrospective study
por: Dudouet, Pierre, et al.
Publicado: (2021)

Characterization of focal hypermetabolic thyroid incidentaloma: An analysis with F-18 fluorodeoxyglucose positron emission tomography/computed tomography parameters
por: Lee, Haejun, et al.
Publicado: (2022)

Characterization of hypermetabolic lymph nodes after SARS-CoV-2 vaccination using PET-CT derived node-RADS, in patients with melanoma
por: Gennari, Antonio G., et al.
Publicado: (2023)

Lymphadenopathy Associated With the COVID-19 Vaccine
por: Hiller, Nurith, et al.
Publicado: (2021)

Correspondence on “hypermetabolic axillary lymph nodes in oncologic patients and COVID-19 vaccination”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Lung mass with bilateral mediastinal hypermetabolic lymphadenopathy in a chronic smoker indicative of lung cancer?
por: Ali, Asghar, et al.
Publicado: (2019)

The value of [(18)F]fluorodeoxyglucose-PET/CT in oesophageal cancer
por: Rankin, S.
Publicado: (2011)

(18)Fluorine-fluorodeoxyglucose PET/CT Imaging in Childhood Malignancies
por: Bıçakçı, Nilüfer, et al.
Publicado: (2021)

Lymphadenopathy after the third Covid-19 vaccine
por: Özütemiz, Can, et al.
Publicado: (2021)

Unilateral lymphadenopathy after COVID-19 vaccination
por: Canan, Arzu, et al.
Publicado: (2021)

Unilateral lymphadenopathy associated with COVID‐19 vaccination
por: Kado, Soichiro, et al.
Publicado: (2021)

Hypermetabolic Axillary Lymph Nodes Associated with COVID-19 Vaccination in Breast Cancer Management
por: Taşçı, Cengiz, et al.
Publicado: (2023)

A case of central pontine and extrapontine myelinolysis with early hypermetabolism on 18FDG-PET scan.
por: Roh, J. K., et al.
Publicado: (1998)

SUBCLINICAL LYMPHADENOPATHY ON FDG-PET IN LUNG CANCER SCREENING AFTER COVID-19 VACCINE BOOSTER
por: NGUYEN, ANH, et al.
Publicado: (2022)

Beyond Covid-19 vaccination-associated pitfalls on [(18)F]Fluorodeoxyglucose (FDG) PET: a case of a concomitant sarcoidosis
por: Bauckneht, Matteo, et al.
Publicado: (2021)

Unusual lymphadenopathies secondary to the BNT162b2 mRNA Covid-19 vaccine
por: Felices-Farias, Jose Manuel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6vev47o0gc9i3b0gjiktu9990h